Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic review

Volume: 12, Issue: 5, Pages: 2280 - 2287
Published: May 1, 2020
Abstract
Background: Stereotactic ablative radiotherapy (SABR) safety and efficacy for mediastinal and hilar lymphadenopathy (MHL) is not yet established, given its potential for toxicity due to the proximity to esophagus and proximal bronchial tree (PBT). This review summarized current reported outcomes of MHL...
Paper Details
Title
Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic review
Published Date
May 1, 2020
Volume
12
Issue
5
Pages
2280 - 2287
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.